| Financial Year |
March 31 2023 |
| Monetary Funds |
686,941,172.81 |
| Held-for-trading Financial Assets |
509,701,088.73 |
| Notes Receivable |
307,256,219.43 |
| Accounts Receivable |
1,459,036,196.29 |
| Advances to Suppliers |
69,728,212.64 |
| Other Receivables |
49,556,029.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,979,422,680.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,573,268.70 |
| Total Current Assets |
5,319,554,549.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,310,038,618.98 |
| Under-construction Projects |
81,901,539.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,044,990.27 |
| R&D expenses |
91,122,256.86 |
| Goodwill |
545,416,159.32 |
| Long-Term Deferred and Prepaid Expenses |
46,879,240.97 |
| Deferred Income Tax Assets |
34,170,672.34 |
| Other Non-Current Assets |
210,565,569.36 |
| Sub-Total of Non-Current Assets |
3,232,872,916.60 |
| Total Assets |
8,552,427,466.09 |
| Short-Term Loans |
434,362,418.44 |
| Trading Financial liabilities |
635,736.92 |
| Notes Payable |
854,014,759.71 |
| Accounts Payable |
1,469,692,239.57 |
| Accounts Received In Advance |
937,269.00 |
| Employee Compensation Payable |
112,644,956.71 |
| Taxes Payable |
28,305,180.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,579,517.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,623,523.14 |
| Other Current Liabilities |
97,591,623.25 |
| Sub-Total of Current Liabilities |
3,083,498,245.74 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,357,300.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
320,754,934.47 |
| Total Liabilities |
3,404,253,180.21 |
| Paid-In Capital(Or Share Stock) |
931,940,685.00 |
| Capital Surplus |
1,127,015,668.98 |
| Surplus Reserve |
221,471,696.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,960,119,930.54 |
| Minority Stockholder's Interest |
745,664,310.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,402,509,975.47 |
| Owner's Equity（Stockholder's Equity） |
5,148,174,285.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,552,427,466.09 |
